The aim of the study was to compare single-dose ertapenem (ERT) with the 3-day regime of ciprofloxacin (CIP) for prophylaxis of possible infections following transrectal prostate biopsy.
Data from a consecutive group of 542 patients from January 2012 to January 2017 were retrospectively analysed.